[Federal Register Volume 71, Number 123 (Tuesday, June 27, 2006)]
[Notices]
[Page 36533]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-5694]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Prescription Opioid Use and Abuse in the Treatment 
of Pain.
    Date: July 27-28, 2006.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Westin Grand, 2350 M Street, NW., Washington, DC 20037.
    Contact Person: Mark R. Green, PhD, Deputy Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 84301, 6101 Executive Boulevard, Bethesda, MD 20892-
8401. (301) 435-1431. [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug 
Abuse and Addiction Research Programs. National Institutes of 
Health, HHS)

    Dated: June 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5694 Filed 6-26-06; 8:45 am]
BILLING CODE 4140-01-M